Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Pathomechanisms and possible interventions in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
Øystein Fluge, … , Karl J. Tronstad, Olav Mella
Øystein Fluge, … , Karl J. Tronstad, Olav Mella
Published July 15, 2021
Citation Information: J Clin Invest. 2021;131(14):e150377. https://doi.org/10.1172/JCI150377.
View: Text | PDF
Viewpoint Article has an altmetric score of 372

Pathomechanisms and possible interventions in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

  • Text
  • PDF
Abstract

Authors

Øystein Fluge, Karl J. Tronstad, Olav Mella

×

Total citations by year

Year: 2025 2024 2023 2022 2021 Total
Citations: 2 7 11 6 2 28
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (28)

Title and authors Publication Year
Deep sequencing of BCR heavy chain repertoires in myalgic encephalomyelitis/chronic fatigue syndrome
Ryback AA, Cowan GJ
Frontiers in Immunology 2025
The Effect on Quality of Life of Therapeutic Plasmapheresis and Intravenous Immunoglobulins on a Population of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients with Elevated β-Adrenergic and M3-Muscarinic Receptor Antibodies—A Pilot Study
Oesch-Régeni B, Germann N, Hafer G, Schmid D, Arn N
Journal of Clinical Medicine 2025
IgG Antibody Responses to Epstein-Barr Virus in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Their Effective Potential for Disease Diagnosis and Pathological Antigenic Mimicry
Fonseca A, Szysz M, Ly HT, Cordeiro C, Sepúlveda N
Medicina 2024
Persistent immune abnormalities discriminate post-COVID syndrome from convalescence.
Sbierski-Kind J, Schlickeiser S, Feldmann S, Ober V, Grüner E, Pleimelding C, Gilberg L, Brand I, Weigl N, Ahmed MIM, Ibarra G, Ruzicka M, Benesch C, Pernpruner A, Valdinoci E, Hoelscher M, Adorjan K, Stubbe HC, Pritsch M, Seybold U, Roider J
Infection 2024
Sex and disease severity-based analysis of steroid hormones in ME/CFS.
Pipper C, Bliem L, León LE, Mennickent D, Bodner C, Guzmán-Gutiérrez E, Stingl M, Untersmayr E, Wagner B, Bertinat R, Sepúlveda N, Westermeier F
Journal of Endocrinological Investigation 2024
Socioeconomic determinants of myalgic encephalomyelitis/chronic fatigue syndrome in Norway: a registry study.
Hilland GH, Anthun KS
BMC Public Health 2024
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease
Arron HE, Marsh BD, Kell DB, Khan MA, Jaeger BR, Pretorius E
Frontiers in immunology 2024
Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Rekeland IG, Sørland K, Neteland LL, Fosså A, Alme K, Risa K, Dahl O, Tronstad KJ, Mella O, Fluge Ø
PloS one 2024
Immunometabolic changes and potential biomarkers in CFS peripheral immune cells revealed by single-cell RNA sequencing.
Sun Y, Zhang Z, Qiao Q, Zou Y, Wang L, Wang T, Lou B, Li G, Xu M, Wang Y, Zhang Z, Hou X, Chen L, Zhao R
Journal of translational medicine 2024
The therapeutic potential of non-invasive brain stimulation for the treatment of Long-COVID-related cognitive fatigue
Linnhoff S, Koehler L, Haghikia A, Zaehle T
Frontiers in immunology 2023
Potential molecular mechanisms of chronic fatigue in long haul COVID and other viral diseases
Gottschalk CG, Peterson D, Armstrong J, Knox K, Roy A
Infectious agents and cancer 2023
Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
Sherif ZA, Gomez CR, Connors TJ, Henrich TJ, Reeves WB
eLife 2023
ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature
Komaroff AL, Lipkin WI
Frontiers in Medicine 2023
The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
Li J, Zhou Y, Ma J, Zhang Q, Shao J, Liang S, Yu Y, Li W, Wang C
Signal Transduction and Targeted Therapy 2023
Why the Psychosomatic View on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Is Inconsistent with Current Evidence and Harmful to Patients.
Thoma M, Froehlich L, Hattesohl DBR, Quante S, Jason LA, Scheibenbogen C
2023
Focus on post-exertional malaise when approaching ME/CFS in specialist healthcare improves satisfaction and reduces deterioration.
Wormgoor MEA, Rodenburg SC
Frontiers in neurology 2023
[Systems thinking, subjective findings and diagnostic "pigeonholing" in ME/CFS: A mainly qualitative public health study from a patient perspective].
Habermann-Horstmeier L, Horstmeier LM
DMW - Deutsche Medizinische Wochenschrift 2023
Exercise Training in Non-Hospitalized Patients with Post-COVID-19 Syndrome-A Narrative Review.
Sick J, König D
2023
Fighting Post-COVID and ME/CFS - development of curative therapies.
Scheibenbogen C, Bellmann-Strobl JT, Heindrich C, Wittke K, Stein E, Franke C, Prüss H, Preßler H, Machule ML, Audebert H, Finke C, Zimmermann HG, Sawitzki B, Meisel C, Toelle M, Krueger A, Aschenbrenner AC, Schultze JL, Beyer MD, Ralser M, Mülleder M, Sander LE, Konietschke F, Paul F, Stojanov S, Bruckert L, Hedderich DM, Knolle F, Riemekasten G, Vehreschild MJGT, Cornely OA, Behrends U, Burock S
Frontiers in Medicine 2023
Endothelial dysfunction in ME/CFS patients.
Sandvik MK, Sørland K, Leirgul E, Rekeland IG, Stavland CS, Mella O, Fluge Ø
PloS one 2023
Perspective: Drawing on Findings From Critical Illness to Explain Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Stanculescu D, Bergquist J
Frontiers in Medicine 2022
Phenotypic characteristics of peripheral immune cells of Myalgic encephalomyelitis/chronic fatigue syndrome via transmission electron microscopy: A pilot study
Jahanbani F, Maynard RD, Sing JC, Jahanbani S, Perrino JJ, Spacek DV, Davis RW, Snyder MP
PloS one 2022
Serum of Post-COVID-19 Syndrome Patients with or without ME/CFS Differentially Affects Endothelial Cell Function In Vitro
Flaskamp L, Roubal C, Uddin S, Sotzny F, Kedor C, Bauer S, Scheibenbogen C, Seifert M
Cells 2022
Treatments of chronic fatigue syndrome and its debilitating comorbidities: a 12-year population-based study.
Leong KH, Yip HT, Kuo CF, Tsai SY
Journal of Translational Medicine 2022
Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS).
Haffke M, Freitag H, Rudolf G, Seifert M, Doehner W, Scherbakov N, Hanitsch L, Wittke K, Bauer S, Konietschke F, Paul F, Bellmann-Strobl J, Kedor C, Scheibenbogen C, Sotzny F
Journal of Translational Medicine 2022
Editorial: Current Insights Into Complex Post-infection Fatigue Syndromes With Unknown Aetiology: The Case of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Beyond.
Westermeier F, Lacerda EM, Scheibenbogen C, Sepúlveda N
Frontiers in Medicine 2022
A map of metabolic phenotypes in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Fredrik Hoel, August Hoel, Ina Pettersen, Ingrid G. Rekeland, Kristin Risa, Kine Alme, Kari Sørland, Alexander Fosså, Katarina Lien, Ingrid Herder, Hanne L Thürmer, Merethe Eide Gotaas, Christoph Schäfer, Rolf Kristian Berge, Kristian Sommerfelt, Hans-Peter Marti, Olav Dahl, Olav Mella, Øystein Fluge, Karl Johan Tronstad
JCI Insight 2021
Lessons From Heat Stroke for Understanding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
D Stanculescu, N Sepúlveda, CL Lim, J Bergquist
Frontiers in neurology 2021

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 11 news outlets
Blogged by 1
Posted by 450 X users
On 8 Facebook pages
Reddited by 1
Referenced by 3 Bluesky users
77 readers on Mendeley
See more details